This content is in French.
Astaxanthin: a promising supplement to reduce inflammation and cellular stress in PCOS
10 janvier 2025
Polycystic ovary syndrome (PCOS) is a common
hormonal disorder in women of reproductive age, characterized by chronic
inflammation, elevated oxidative stress, and abnormalities in cell death
mechanisms (apoptosis). These biological imbalances contribute to issues such
as irregular ovulation, hormonal disturbances, and other PCOS symptoms.
In this context, astaxanthin (ASX), a potent antioxidant, is being investigated for its potential to reduce inflammation and improve cellular function by modulating endoplasmic reticulum stress and apoptosis. These effects may enhance ovarian function and provide new therapeutic avenues for women with PCOS.
In this context, astaxanthin (ASX), a potent antioxidant, is being investigated for its potential to reduce inflammation and improve cellular function by modulating endoplasmic reticulum stress and apoptosis. These effects may enhance ovarian function and provide new therapeutic avenues for women with PCOS.
What are the effects of astaxanthin on inflammation and cellular stress in PCOS?
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Jabarpour, M., et al. (2024). Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS. Journal of cellular and molecular medicine, 28(14), e18464.
View the source
